Bristol Myers Squibb
Prescription Drugs · Oncology Therapeutics

Bristol Myers Squibb revenue, results and funding

Bristol Myers Squibb filed revenue of $48.2B for 2025.

Data updated Nov 21, 2026 · Back to the company report
$48.2BRevenue, 2025
$7.1BNet income, 2025
30,000Employees, 2019
BMYNew York Stock Exchange

Results by year

YearRevenueNet incomeTotal assetsEmployeesLANG_CR_S_M_TAX_PAIDLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_DIVIDENDSLANG_CR_S_M_BUYBACKSLANG_CR_S_M_CAPEXLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_CASHLANG_CR_S_M_DEBTLANG_CR_S_M_ACQUISITIONS
2025$48.2B$7.1B$90B–$3.3B$2.3B$5B$0$1.3B$553M$10B$10.2B$42.9B$3.9B
2024$48.3B−$8.9B$92.6B–$3.9B$554M$4.9B$0$1.2B$507M$11.2B$10.3B$47.6B$21.8B
2023$45B$8B$95.2B–$4.3B$400M$4.7B$5.2B$1.2B$518M$9.3B$11.5B$36.7B$1.2B
2022$46.2B$6.3B$96.8B–$5.4B$1.4B$4.6B$8B$1.1B$457M$9.5B$9.1B$35.1B$4.3B
2021$46.4B$7B$109.3B–$3.5B$1.1B$4.4B$6.3B$973M$583M$10.2B$14B$39.6B$1.6B
2020$42.5B−$9B$118.5B–$3.4B$2.1B$4.1B$1.5B$753M$779M$10B$14.5B$48.3B$13.1B
2019$26.1B$3.4B$128.1B30,000$1.5B$1.5B$2.7B$7.3B$836M$441M$6.1B$19.9B$43.4B$24.8B
2018$22.6B$4.9B$55.2B–$747M$1B$2.6B$320M$951M$221M$6.3B$28.4B$5.6B$2.4B
2017$20.8B$1B$32.6B–$546M$4.2B$2.6B$2.5B$1.1B$199M$6.5B$5B$7B$726M
2016$19.4B$4.5B$33.4B–$2B$1.4B$2.5B$231M$1.2B$205M$5B$3.5B$5.7B$359M
2015$16.6B$1.6B$32.8B–$577M$446M$2.5B–$820M$235M$5.9B$2.4B$6.6B$1.1B
2014$15.9B$2B$32B–$544M$352M$2.4B–$526M$213M$4.5B$5.6B$6.6B$219M
2013$16.4B$2.6B$33.5B–$478M$311M$2.3B$433M$537M$191M$3.7B$3.6B$7.4B–
2012$17.6B$2B$36.3B–$676M−$161M$2.3B$2.4B$548M$154M$3.9B$1.7B$6.6B$7.5B
2011$21.2B$3.7B$31.7B–$597M$1.7B$2.3B$1.2B$367M$161M$3.8B$5.8B$5.4B$360M
Sources: SEC, Wikidata

How to cite

Bristol Myers Squibb, Financials. Alion, Nov 21, 2026. https://alion.io/company/bms/financials

.json · .md · CC BY-SA 4.0